|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA03110268
|
ent-8,11-diepi-8-A2-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214410
|
|
LMFA04010357
|
7,14-diepi-14-E4c-NeuroP
|
(Z)-6-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224975
|
|
LMFA04010076
|
ent-16-epi-13-F4c-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
|
LMFA04010094
|
ent-14-F4c-NeuroP
|
(Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
|
LMFA04010106
|
14-F4t-NeuroP
|
(Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
|
LMFA04010135
|
20-F4c-NeuroP
|
(4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
|
LMFA04010223
|
ent-14-epi-14-D4t-NeuroP
|
(Z)-6-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224975
|
|
LMFA04010231
|
14-D4c-NeuroP
|
(Z)-6-((1R,2S,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224975
|
|
LMFA04010261
|
13,20-diepi-20-D4c-NeuroP
|
(4Z,7Z,10Z)-12-((1S,2S,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224975
|
|
LMFA04010284
|
ent-10-epi-7-E4c-NeuroP
|
(R,4Z,8E)-7-hydroxy-9-((1R,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224975
|
|
LMFA04010316
|
ent-4-epi-11-E4c-NeuroP
|
3-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224975
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA03110319
|
ent-14-F2c-dihomo-IsoP
|
1a,1b-dihomo-8R,10S,14R-trihydroxy-12E,16Z-prostadienoic acid-cyclo[7S,11R]
|
FA 22:3;O3
|
C22H38O5
|
382.271925
|
|
LMFA01160047
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
FA 59:1;O
|
C59H116O3
|
872.892445
|
|
LMFA01160047
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
FA 59:1;O
|
C59H116O3
|
872.892445
|
|
LMFA01160047
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
FA 59:1;O
|
C59H116O3
|
872.892445
|
|
LMFA01160065
|
2-tetracosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
2-tetracosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
FA 74:0;O2
|
C74H148O4
|
1101.137760
|
|
LMFA04010151
|
4-D4c-NeuroP
|
(S,E)-4-hydroxy-6-((1R,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224975
|
|
LMFA04010180
|
ent-10,13-diepi-10-D4c-NeuroP
|
(S,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224975
|
|
LMFA04010509
|
10,17-diepi-17-J4-NeuroP
|
(4Z,7Z)-9-((1R,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA01160075
|
2-tetracosyl-3-hydroxy-32-oxo-33-methyl-henpentacontanoic acid
|
2-tetracosyl-3-hydroxy-32-oxo-33-methyl-henpentacontanoic acid
|
FA 76:1;O2
|
C76H150O4
|
1127.153410
|
|
LMFA01160107
|
2-docosyl-3-hydroxy-32,33-epoxy-34-methyl-pentacontanoic acid
|
2-docosyl-3-hydroxy-32,33-epoxy-34-methyl-pentacontanoic acid
|
FA 73:1;O2
|
C73H144O4
|
1085.106460
|
|
LMFA01160122
|
2-eicosyl-3-hydroxy-30-carboxy-triacontanoic acid
|
2-eicosyl-3-hydroxy-30-carboxy-triacontanoic acid
|
FA 51:1;O3
|
C51H100O5
|
792.757075
|
|
LMFA08030031
|
N-(3-oxo-pentanoyl)-homoserine lactone
|
N-(3-oxo-pentanoyl)-homoserine lactone
|
|
C9H13NO4
|
199.084459
|
|
LMFA08030037
|
N-(3-hydroxy-decanoyl)-homoserine lactone
|
N-(3-hydroxy-decanoyl)-homoserine lactone
|
|
C14H25NO4
|
271.178359
|
|
LMFA01010047
|
Stearic acid(d3)
|
Octadecanoic acid(d3)
|
|
C18H33D3O2
|
287.290361
|
|
LMFA07090036
|
FAHFA 16:0/9O(FA 16:0)
|
9-hexadecanoyloxy-hexadecanoic acid
|
FAHFA 32:0;O
|
C32H62O4
|
510.464810
|
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA01170140
|
Graminoxin A1
|
2-pentyl-4Z-tridecene-1,13-dioic acid
|
FA 18:2;O2
|
C18H32O4
|
312.230060
|
|
LMFA03060003
|
11S-HETE
|
11S-hydroxy-5Z,8Z,12E,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235145
|
|
LMFA03060003
|
11S-HETE
|
11S-hydroxy-5Z,8Z,12E,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235145
|
|
LMFA03060003
|
11S-HETE
|
11S-hydroxy-5Z,8Z,12E,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235145
|
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
|
LMFA03090002
|
Trioxilin A3
|
8,11R,12S-trihydroxy-5Z,9E,14Z-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240625
|
|
LMFA03090002
|
Trioxilin A3
|
8,11R,12S-trihydroxy-5Z,9E,14Z-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240625
|
|
LMFA03090002
|
Trioxilin A3
|
8,11R,12S-trihydroxy-5Z,9E,14Z-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240625
|
|
LMFA03030004
|
11-dehydro-TXB2
|
9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219890
|
|
LMFA03030004
|
11-dehydro-TXB2
|
9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219890
|
|
LMFA03030004
|
11-dehydro-TXB2
|
9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219890
|
|
LMFA03030004
|
11-dehydro-TXB2
|
9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219890
|
|
LMFA03080002
|
(+/-)5,6-EpETrE
|
5,6-epoxy-8Z,11Z,14Z-eicosatrienoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235145
|